Janiczek Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$10.2K Hold
90
﹤0.01% 654
2024
Q1
$12.5K Hold
90
﹤0.01% 643
2023
Q4
$11.2K Buy
90
+77
+592% +$7.87K ﹤0.01% 650
2023
Q3
$1.21K Hold
13
﹤0.01% 891
2023
Q2
$1.67K Hold
13
﹤0.01% 787
2023
Q1
$1.5K Buy
+13
New +$1.46K ﹤0.01% 798
2022
Q4
Sell
-4
Closed 1046
2022
Q3
$0 Hold
4
﹤0.01% 946
2022
Q2
$0 Hold
4
﹤0.01% 974
2022
Q1
$1K Hold
4
﹤0.01% 852
2021
Q4
$1K Hold
4
﹤0.01% 906
2021
Q3
$1K Buy
+4
New +$504 ﹤0.01% 884

Other funds holding DXCM

Janiczek Wealth Management's DXCM Position: Q2 2024 in Review

Janiczek Wealth Management held its DexCom (DXCM) position steady in Q2 2024 at 90 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Janiczek Wealth Management first reported a position in DXCM in Q3 2021 and has held it in 11 quarters since. The position peaked at $12.5K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Janiczek Wealth Management held 90 shares of DexCom worth $10.2K as of Q2 2024.
  • Janiczek Wealth Management left its DexCom share count unchanged in Q2 2024.
  • DexCom made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #654 holding.
  • Janiczek Wealth Management first reported a position in DexCom in Q3 2021 and has held it in 11 quarters since.
  • Janiczek Wealth Management's DexCom position peaked at $12.5K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.